{
  "created_at": "Mon Sep 27 7:34:36 +0000 2021",
  "id_str": "1442383527761350656",
  "full_text": "AstraZeneca said its breast cancer drug Enhertu significantly reduced the risk of dying or disease progression in women with advanced disease in a large clinical trial https://t.co/dkHZwmUb4c",
  "display_text_range": [
    0,
    191
  ],
  "entities": {
    "hashtags": [],
    "symbols": [],
    "user_mentions": [],
    "urls": [
      {
        "url": "https://t.co/dkHZwmUb4c",
        "expanded_url": "https://on.wsj.com/3o9LrN3",
        "display_url": "on.wsj.com/3o9LrN3",
        "indices": [
          168,
          191
        ]
      }
    ]
  },
  "user": {
    "name": "The Wall Street Journal",
    "screen_name": "WSJ",
    "profile_image_url_https": "https://pbs.twimg.com/profile_images/971415515754266624/zCX0q9d5_normal.jpg"
  },
  "retweet_count": 27,
  "favorite_count": 99,
  "possibly_sensitive": false,
  "original_created_at": "Mon Sep 27 07:00:05 +0000 2021"
}